Own the first one you mentioned. This is my largest holding in both shares and percentage of my porfolio. I like seeing a 4% gain but would like a string of them. In due time. Once we get all the P2 up and running I think it's going to move over a buck and stay there regardless of warrants being exersised and sold quickly into the float. Trials are ready and they are close to beginning recruitment of patients. I think by next year we will have another partner in Roche/Genentech. They will run a number of combos with Herceptin.
News 
Market Data 
Discover 
